136 related articles for article (PubMed ID: 1288908)
1. Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Can J Anaesth; 1992 Oct; 39(8):816-21. PubMed ID: 1288908
[TBL] [Abstract][Full Text] [Related]
2. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
[TBL] [Abstract][Full Text] [Related]
3. Sevoflurane has no effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Cuillerier DJ; Lee JK; Basta M; Krahn AD; Klein GJ; Yee R
Anesthesiology; 1999 Jan; 90(1):60-5. PubMed ID: 9915313
[TBL] [Abstract][Full Text] [Related]
4. The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Anesthesiology; 1994 Jan; 80(1):63-70. PubMed ID: 8291732
[TBL] [Abstract][Full Text] [Related]
5. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
6. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
8. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction.
Rinne C; Sharma AD; Klein GJ; Yee R; Szabo T
Am Heart J; 1988 May; 115(5):1042-7. PubMed ID: 3364337
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern.
Kubuš P; Vít P; Gebauer RA; Materna O; Janoušek J
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):218-23. PubMed ID: 24488978
[TBL] [Abstract][Full Text] [Related]
11. Effects of verapamil on accessory pathway properties and induction of circus movement tachycardia in patients with the Wolf-Parkinson-White syndrome.
Matsuyama E; Konishi T; Okazaki H; Matsuda H; Kawai C
J Cardiovasc Pharmacol; 1981; 3(1):11-24. PubMed ID: 6160340
[TBL] [Abstract][Full Text] [Related]
12. [Effect of heart rate on the refractory period of the accessory atrioventricular pathway in Wolff-Parkinson-White syndrome].
Fromer M; Gloor H; Kappenberger L
Schweiz Med Wochenschr; 1985 Nov; 115(44):1545-51. PubMed ID: 4081683
[TBL] [Abstract][Full Text] [Related]
13. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of exercise and isoproterenol on the antegrade refractory period of the accessory pathway in patients with Wolff-Parkinson-White syndrome.
Yamabe H; Okumura K; Yasue H
Jpn Circ J; 1994 Jan; 58(1):22-8. PubMed ID: 8139088
[TBL] [Abstract][Full Text] [Related]
15. Retrograde atrial preexcitation following premature ventricular beats during reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Sellers TD; Gallagher JJ; Cope GD; Tonkin AM; Wallace AG
Eur J Cardiol; 1976 Sep; 4(3):283-94. PubMed ID: 964277
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of ibutilide in patients with accessory pathways.
Glatter KA; Dorostkar PC; Yang Y; Lee RJ; Van Hare GF; Keung E; Modin G; Scheinman MM
Circulation; 2001 Oct; 104(16):1933-9. PubMed ID: 11602497
[TBL] [Abstract][Full Text] [Related]
17. [Electrophysiologic effects of isoproterenol in children with Wolff-Parkinson-White syndrome].
Fujiseki Y; Fujino H; Hattori M; Kamiya Y; Nishijima S; Umemura N; Shimada M; Sugiyama T; Matsukawa S; Nishikawa R
Kokyu To Junkan; 1989 Feb; 37(2):189-94. PubMed ID: 2727406
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
19. Effect of lidocaine on atrioventricular response via the accessory pathway in patients with Wolff-Parkinson-White syndrome.
Akhtar M; Gilbert CJ; Shenasa M
Circulation; 1981 Feb; 63(2):435-41. PubMed ID: 7449065
[No Abstract] [Full Text] [Related]
20. Pacing site and bradycardia dependent retrograde conduction block over an atrioventricular accessory pathway.
Bai R; Tritto M; Di Biase L; Salerno-Uriarte JA
Europace; 2006 Jun; 8(6):438-42. PubMed ID: 16648245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
